Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Danaher

GlaxoSmithKline

IQVIA Hlds

Intuitive Surgical

Jazz Pharmaceuticals

LHC Group

Moderna

Invesco S&P 500 Equal Weight Health Care ETF

UnitedHealth Group

Vertex Pharmaceuticals

The 2020s could be the decade of healthcare stocks. Here are 10 companies and one ETF to watch not just for the remainder of this year, but well beyond.

11 Best Healthcare Stocks for the Rest of 2021

Fab 5 Freddy's B Noble Inc. has teamed up with Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) to launch the B Noble brand in Massachusetts and Maryland. The partnership is part of Curaleaf's Rooted in Good corporate social responsibility program

Fab 5 Freddy And B Noble Inc. Team Up With Curaleaf To Launch B Noble Cannabis Brand

Launch of Pre-Roll Product Supports a Shared Commitment to Advance Social Equity in Cannabis and Provides Opportunity to Those Directly Impacted by the War on Drugs WAKEFIELD, Mass., July 13, 2021 /PRNewswire/ -- B Noble Inc. and Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the launch of the B Noble brand in Massachusetts and Maryland, with a national rollout continuing into Fall 2021.

Bernard Noble and Fab 5 Freddy Partner with Curaleaf to Launch B Noble Brand

2 Marijuana Stocks To Watch 2nd Half Of July The post Are These Marijuana Stocks Worth Buying Right Now? 2 To Watch In July appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are These Marijuana Stocks Worth Buying Right Now? 2 To Watch In July

WAKEFIELD, Mass., July 12, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, announced today that Ranjan Kalia will join the company as Chief Financial Officer on July 19, 2021.

Curaleaf Appoints Ranjan Kalia As Chief Financial Officer

GrowGeneration Corp

Green Thumb Industries Inc.

Are These 3 Marijuana Stocks Well Builders For Cannabis Investors? The post Looking For the Best Marijuana Stocks To Buy In 2021? 3 To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Looking For the Best Marijuana Stocks To Buy In 2021? 3 To Watch Right Now

Trulieve Cannabis Corp.

These high-flying pot stocks can add a great deal of weight to your portfolio.

3 Top Pot Stocks to Watch in July

Aurora Cannabis

Canopy Growth

Tilray Brands

The Cannabis Growth Portfolio is the premier research service in the cannabis sector. Nearly 40 states have already legalized medical cannabis, and I expect more dominoes to fall over the next 10 years.

Launching The Cannabis Growth Portfolio: The Generational Buying Opportunity In Cannabis

LONDON--(BUSINESS WIRE)--Curaleaf International (formerly EMMAC Life Sciences Group) (“Curaleaf International”), Europe's largest vertically integrated cannabis company, is pleased to announce it has successfully exported over one metric ton of medical cannabis to BOL Pharma in Israel. Curaleaf International is one of the first companies to export medical cannabis to Israel under the country's new regulatory regime. The initial shipment, comprising two strains of dried flower, was shipped from

Curaleaf International Exports Over a Ton of Medical Cannabis Flower to Israel; One of the First Companies to Do so Under New Regulatory Regime

AdvisorShares Pure US Cannabis ETF

Annual retail sales of cannabis in the U.S. will increase to $64 billion by 2030 from $17.2 billion in 2020, one analyst estimates.

U.S. Pot Stocks Are Wealth Builders, Analyst Says. The Stocks Jumped.

They are some of the biggest names in the industry, and they already have presences in the state.

These 3 MSOs Are Ready for Connecticut's New Recreational Marijuana Market

Agrify

Agrify Corporation (NASDAQ:AGFY) has teamed up with Curaleaf Holdings, Inc. (OTCQX:CURLF) to determine the impact of the cultivation environment on the overall health of cannabis plants and harvest yields. Under the deal, the Massachusetts-based company agreed to provide the use of its Agrify Insights software platform for three years to Curaleaf's facility located in the Bay State.

Agrify And Curaleaf Study Impact Of Cannabis Cultivation On Plant Health And Harvest Yields, Curaleaf International Expands

LONDON--(BUSINESS WIRE)--Curaleaf International (formerly EMMAC Life Sciences Group) (“Curaleaf International”), Europe's largest vertically integrated cannabis company, is pleased to announce that Medalchemy, the Group's Good Manufacturing Practice (“GMP”) certified manufacturing site in Alicante, Spain has secured approval from the Spanish Health Authorities (“AEMPS”) to import, manufacture and export medical cannabis flower. Medalchemy now has fully integrated cannabis supply facilities, wit

Curaleaf International Secures Complete GMP Certification of Second EU GMP Facility in Europe

Could These Top Marijuana Stocks Could Hold Future Upside For Investors? The post Best Marijuana Stocks For Your Watchlist In July? 3 Top US Pot Stocks To Check Out appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Marijuana Stocks For Your Watchlist In July? 3 Top US Pot Stocks To Check Out

Top Marijuana Stocks To Watch This Month The post Top Marijuana Stocks To Watch To Close Out The Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Watch To Close Out The Week

WAKEFIELD, Mass., July 1, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the second quarter ended June 30, 2021 after market close on August 9, 2021.

Curaleaf to Report Second Quarter 2021 Financial and Operational Results

As Curaleaf International's subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa, with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological therapies. Based in London, Curaleaf said Tuesday the first treatment will be launched in Germany in the months to come.

Curaleaf International's Subsidiary Teams Up With Germany's Zambon Spa To Provide Medical Cannabis Treatments

Companies big and small will face the necessary evils of regulations.

This Cannabis Behemoth May Have to Yield Some Revenue to Mom-and-Pop Shops

LONDON, June 29, 2021 /PRNewswire/ -- Curaleaf International (formerly EMMAC Life Sciences Group), Europe's largest vertically integrated cannabis company, is pleased to announce that its wholly owned subsidiary, Adven GmbH ("Adven"), has announced a strategic partnership with Zambon GmbH, the German subsidiary of Zambon Spa, an Italian multinational pharmaceutical company, leading in Parkinson's Disease, severe respiratory diseases and pain. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies.

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Pot companies may do better dealing with a fairer tax code than navigating a regulatory labyrinth.

Do Cannabis Stocks Need Tax Reform More Than Legalization?

These Top US Marijuana Stocks Could Be Big Gainers In 2021 The post Best Ways To Invest In Top Marijuana Stocks In 2021? 5 Cannabis Stocks For Your Watchlist Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Ways To Invest In Top Marijuana Stocks In 2021? 5 Cannabis Stocks For Your Watchlist Next Week

These Could Be Some Of The Best Cannabis Stocks In The US In 2021 The post Which Top Marijuana Stocks Would You Buy Right Now? 2 With Upside According To Analysts appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Which Top Marijuana Stocks Would You Buy Right Now? 2 With Upside According To Analysts

Opening Marks Company's 107th Retail Location Nationwide Strategic Expansion Will Help Serve the State's Rapidly Growing Cannabis Market WAKEFIELD, Mass., June 24, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the opening of Curaleaf Edgewater Park, the Company's second dispensary in New Jersey and 107th dispensary nationwide.

Curaleaf Expands Presence in New Jersey with New Dispensary and Cultivation Facility

Nothing is certain, but the prospects are better than they've ever been.

Why Investors Can Be Cautiously Optimistic About Major Cannabis Reform in the U.S.

After Connecticut Gov. Ned Lamont signed an adult-use cannabis bill into law on Tuesday, making it the 18th U.S. state to legalize marijuana, Cantor Fitzgerald's Pablo Zuanic shared his insights on the new market.

Cantor Fitzgerald: Curaleaf And Green Thumb Best Positioned To Thrive In Connecticut's New Cannabis Market

News for Curaleaf Holdings, Inc. Stock (CURLF)